C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice.
McNamara DJ, Dobrusin E, Leonard DM, Shuler KR, Kaltenbronn JS, Quin J 3rd, Bur S, Thomas CE, Doherty AM, Scholten JD, Zimmerman KK, Gibbs BS, Gowan RC, Latash MP, Leopold WR, Przybranowski SA, Sebolt-Leopold JS.
McNamara DJ, et al. Among authors: shuler kr.
J Med Chem. 1997 Oct 10;40(21):3319-22. doi: 10.1021/jm970470c.
J Med Chem. 1997.
PMID: 9341905
No abstract available.